QQQ   445.61 (+1.51%)
AAPL   179.66 (-0.60%)
MSFT   415.50 (+0.45%)
META   502.30 (+2.48%)
GOOGL   137.14 (-0.95%)
AMZN   178.22 (+0.83%)
TSLA   202.64 (+0.38%)
NVDA   822.79 (+4.00%)
NIO   5.77 (+0.35%)
AMD   202.64 (+5.25%)
BABA   74.63 (+0.81%)
T   17.00 (+0.41%)
F   12.45 (+0.08%)
MU   95.15 (+5.01%)
CGC   3.21 (-2.43%)
GE   158.67 (+1.13%)
DIS   111.93 (+0.31%)
AMC   4.36 (+0.93%)
PFE   26.58 (+0.08%)
PYPL   60.54 (+0.33%)
XOM   105.78 (+1.21%)
QQQ   445.61 (+1.51%)
AAPL   179.66 (-0.60%)
MSFT   415.50 (+0.45%)
META   502.30 (+2.48%)
GOOGL   137.14 (-0.95%)
AMZN   178.22 (+0.83%)
TSLA   202.64 (+0.38%)
NVDA   822.79 (+4.00%)
NIO   5.77 (+0.35%)
AMD   202.64 (+5.25%)
BABA   74.63 (+0.81%)
T   17.00 (+0.41%)
F   12.45 (+0.08%)
MU   95.15 (+5.01%)
CGC   3.21 (-2.43%)
GE   158.67 (+1.13%)
DIS   111.93 (+0.31%)
AMC   4.36 (+0.93%)
PFE   26.58 (+0.08%)
PYPL   60.54 (+0.33%)
XOM   105.78 (+1.21%)
QQQ   445.61 (+1.51%)
AAPL   179.66 (-0.60%)
MSFT   415.50 (+0.45%)
META   502.30 (+2.48%)
GOOGL   137.14 (-0.95%)
AMZN   178.22 (+0.83%)
TSLA   202.64 (+0.38%)
NVDA   822.79 (+4.00%)
NIO   5.77 (+0.35%)
AMD   202.64 (+5.25%)
BABA   74.63 (+0.81%)
T   17.00 (+0.41%)
F   12.45 (+0.08%)
MU   95.15 (+5.01%)
CGC   3.21 (-2.43%)
GE   158.67 (+1.13%)
DIS   111.93 (+0.31%)
AMC   4.36 (+0.93%)
PFE   26.58 (+0.08%)
PYPL   60.54 (+0.33%)
XOM   105.78 (+1.21%)
QQQ   445.61 (+1.51%)
AAPL   179.66 (-0.60%)
MSFT   415.50 (+0.45%)
META   502.30 (+2.48%)
GOOGL   137.14 (-0.95%)
AMZN   178.22 (+0.83%)
TSLA   202.64 (+0.38%)
NVDA   822.79 (+4.00%)
NIO   5.77 (+0.35%)
AMD   202.64 (+5.25%)
BABA   74.63 (+0.81%)
T   17.00 (+0.41%)
F   12.45 (+0.08%)
MU   95.15 (+5.01%)
CGC   3.21 (-2.43%)
GE   158.67 (+1.13%)
DIS   111.93 (+0.31%)
AMC   4.36 (+0.93%)
PFE   26.58 (+0.08%)
PYPL   60.54 (+0.33%)
XOM   105.78 (+1.21%)

Krystal Biotech (KRYS) SEC Filings & 10K Form

$167.82
+8.35 (+5.24%)
(As of 03/1/2024 ET)

Recent Krystal Biotech SEC Filings

DateFilerForm TypeView
02/28/2024
8:39 PM
Krishnan Suma (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
8:33 PM
Krystal Biotech (Issuer)
ROMANO KATHRYN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
8:36 PM
Krishnan Krish S (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2024
12:35 PM
Krystal Biotech (Subject)
ROMANO KATHRYN (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2024
6:59 AM
Krystal Biotech (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/26/2024
7:04 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/26/2024
6:49 AM
Krystal Biotech (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2024
8:25 AM
Avoro Capital Advisors LLC (Filed by)
Krystal Biotech (Subject)
Form SC 13G/A
01/29/2024
2:26 PM
Krystal Biotech (Subject)
Form SC 13G/A
01/24/2024
4:44 PM
Krystal Biotech (Issuer)
Romano Kathryn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2024
10:43 AM
Krystal Biotech (Subject)
Romano Kathryn (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/12/2023
4:17 PM
Krishnan Krish S (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2023
4:23 PM
Krishnan Suma (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2023
3:19 PM
Krishnan Krish S (Reporting)
Krystal Biotech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/11/2023
3:20 PM
Krishnan Suma (Reporting)
Krystal Biotech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/06/2023
6:08 AM
Krystal Biotech (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2023
6:10 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2023
11:07 AM
Krystal Biotech (Subject)
ORTH ANDREW C. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/12/2023
4:59 PM
Krishnan Krish S (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2023
5:01 PM
Krishnan Suma (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2023
3:16 PM
Krishnan Suma (Reporting)
Krystal Biotech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/11/2023
3:16 PM
Krishnan Krish S (Reporting)
Krystal Biotech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/21/2023
4:30 PM
Krystal Biotech (Subject)
ORTH ANDREW C. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/16/2023
3:57 PM
Krystal Biotech (Subject)
ORTH ANDREW C. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/15/2023
3:56 PM
Krystal Biotech (Subject)
ORTH ANDREW C. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/10/2023
5:06 PM
Krystal Biotech (Subject)
ORTH ANDREW C. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/07/2023
7:18 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2023
6:07 AM
Krystal Biotech (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2023
6:13 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/18/2023
3:05 PM
Krystal Biotech (Filer)
Form S-3ASR
07/03/2023
3:35 PM
Krystal Biotech (Issuer)
Mazzacco Catherine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2023
3:20 PM
JANNEY DANIEL (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2023
3:24 PM
Krystal Biotech (Issuer)
Mason Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2023
3:27 PM
Krystal Biotech (Issuer)
ROSSI DINO A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2023
3:31 PM
Krystal Biotech (Issuer)
Sutherland Everett Rand (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2023
3:16 PM
Gangolli Julian S (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2023
6:00 PM
Krystal Biotech (Issuer)
ORTH ANDREW C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2023
6:03 PM
JANNEY DANIEL (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2023
5:21 PM
Krishnan Krish S (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2023
5:23 PM
Krishnan Suma (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2023
3:23 PM
Krishnan Suma (Reporting)
Krystal Biotech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/22/2023
3:35 PM
Krystal Biotech (Subject)
Romano Kathryn (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/22/2023
6:32 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/11/2023
6:33 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2023
8:45 AM
FMR LLC (Filed by)
Krystal Biotech (Subject)
Form SC 13G/A
05/08/2023
7:48 AM
Krystal Biotech (Filer)
Form 424B5
05/08/2023
7:51 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2023
7:25 AM
Krystal Biotech (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2023
7:27 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/24/2023
6:04 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/19/2023
3:19 PM
JANNEY DANIEL (Reporting)
Krystal Biotech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/17/2023
3:50 PM
Krishnan Suma (Reporting)
Krystal Biotech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/17/2023
3:51 PM
Krishnan Krish S (Reporting)
Krystal Biotech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/06/2023
3:43 PM
Krystal Biotech (Filer)
Form S-3ASR
04/04/2023
3:20 PM
Krystal Biotech (Filer)
Form DEF 14A
04/04/2023
3:21 PM
Krystal Biotech (Filer)
Form DEFA14A
03/09/2023
5:26 PM
Krystal Biotech (Issuer)
Mazzacco Catherine (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/28/2023
5:39 PM
Krishnan Krish S (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2023
5:41 PM
Krishnan Suma (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2023
5:43 PM
Krystal Biotech (Issuer)
Romano Kathryn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2023
5:45 PM
Krystal Biotech (Issuer)
ORTH ANDREW C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:KRYS) was last updated on 3/1/2024 by MarketBeat.com Staff